124 related articles for article (PubMed ID: 9199883)
1. Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme.
O'Neil J; Hoppe G; Sayre LM; Hoff HF
Free Radic Biol Med; 1997; 23(2):215-25. PubMed ID: 9199883
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages.
Hoppe G; O'Neil J; Hoff HF
J Clin Invest; 1994 Oct; 94(4):1506-12. PubMed ID: 7929826
[TBL] [Abstract][Full Text] [Related]
3. Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages.
Hoff HF; Zyromski N; Armstrong D; O'Neil J
J Lipid Res; 1993 Nov; 34(11):1919-29. PubMed ID: 8263416
[TBL] [Abstract][Full Text] [Related]
4. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues.
Crabb JW; O'Neil J; Miyagi M; West K; Hoff HF
Protein Sci; 2002 Apr; 11(4):831-40. PubMed ID: 11910026
[TBL] [Abstract][Full Text] [Related]
5. A simple method for the assessment of macrophage scavenger receptor-ligand interaction: adherence of erythrocytes coated with oxidized low density lipoprotein and modified albumin to macrophages.
Beppu M; Hora M; Kikugawa K
Biol Pharm Bull; 1994 Jan; 17(1):39-46. PubMed ID: 8148814
[TBL] [Abstract][Full Text] [Related]
6. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36.
Unno Y; Sakai M; Sakamoto Y; Kuniyasu A; Nakayama H; Nagai R; Horiuchi S
Biochem Biophys Res Commun; 2004 Dec; 325(1):151-6. PubMed ID: 15522213
[TBL] [Abstract][Full Text] [Related]
8. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition.
Hoff HF; Whitaker TE; O'Neil J
J Biol Chem; 1992 Jan; 267(1):602-9. PubMed ID: 1730620
[TBL] [Abstract][Full Text] [Related]
11. Phospholipids in oxidized low density lipoproteins perturb the ability of macrophages to degrade internalized macromolecules and reduce intracellular cathepsin B activity.
O'Neil J; Hoppe G; Hoff HF
Atherosclerosis; 2003 Aug; 169(2):215-24. PubMed ID: 12921972
[TBL] [Abstract][Full Text] [Related]
12. Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages.
Sakai M; Miyazaki A; Hakamata H; Suginohara Y; Sakamoto YI; Morikawa W; Kobori S; Schichiri M; Horiuchi S
Atherosclerosis; 1996 Jan; 119(2):191-202. PubMed ID: 8808496
[TBL] [Abstract][Full Text] [Related]
13. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL.
Kato Y; Tokunaga K; Osawa T
Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712
[TBL] [Abstract][Full Text] [Related]
15. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
16. Modification of delipidated apoprotein B of low density lipoprotein by lipid oxidation products in relation to macrophage scavenger receptor binding.
Alaiz M; Beppu M; Ohishi K; Kikugawa K
Biol Pharm Bull; 1994 Jan; 17(1):51-7. PubMed ID: 8148817
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB.
Nishimura S; Akagi M; Yoshida K; Hayakawa S; Sawamura T; Munakata H; Hamanishi C
Osteoarthritis Cartilage; 2004 Jul; 12(7):568-76. PubMed ID: 15219572
[TBL] [Abstract][Full Text] [Related]
18. Hypochlorous acid-modified low-density lipoprotein inactivates the lysosomal protease cathepsin B: protection by ascorbic and lipoic acids.
Carr AC
Redox Rep; 2001; 6(6):343-9. PubMed ID: 11865974
[TBL] [Abstract][Full Text] [Related]
19. Repair of amino acid radicals of apolipoprotein B100 of low-density lipoproteins by flavonoids. A pulse radiolysis study with quercetin and rutin.
Filipe P; Morlière P; Patterson LK; Hug GL; Mazière JC; Mazière C; Freitas JP; Fernandes A; Santus R
Biochemistry; 2002 Sep; 41(36):11057-64. PubMed ID: 12206678
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional properties of apolipoprotein B in chemically modified low density lipoproteins.
Vanderyse L; Devreese AM; Baert J; Vanloo B; Lins L; Ruysschaert JM; Rosseneu M
Atherosclerosis; 1992 Dec; 97(2-3):187-99. PubMed ID: 1466663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
